Cellply vs Element Biosciences
Cellply vs Element Biosciences, compared side by side on 13 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Cellply is on 52/100 and Element Biosciences on 53/100.
Where each one leads
Cellply
Leads on none of the measures we hold for both companies.
Element Biosciences
- funding raised: $175M against $7.2M
At a glance
| Measure | Cellply | Element Biosciences |
|---|---|---|
| What it is | DeepTech startup developing analytical tools for characterization of cancer immunotherapies, cell therapies, and cell-based biotherapeutics. | Revolutionizing genomic analysis with innovative sequencing technology. |
| Category | Biotechnology, HealthTech, Artificial Intelligence, Medical Devices | Biotechnology, Genomics, Life Sciences, Healthcare Technology |
| Sells toBusiness model | B2B | B2B |
| Offering | Hardware | Hardware |
| Founded | 2013 | 2017 |
| Headquarters | Bologna, Italy | San Diego, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | Cellply | Element Biosciences |
|---|---|---|
| Employees | 25 | Not published |
| Total funding | $7.2M | $175M |
| Latest round | Funding Round | Series E |
| Valuation | Not published | $1.1B |
| LinkedIn followers | 9,134 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Cellply | Element Biosciences |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 52/100 | 53/100 |
| Traction | 48/100 | 40/100 |
| Team | 60/100 | Not published |
| Community | 15/100 | Not published |
| Search visibility | 33/100 | 2/100 |
| Quality | 58/100 | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | Not published | F (34/100) |
| Domain ratingLink authority, 0-100 | Not published | 66/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Cellply | Element Biosciences |
|---|---|---|
| CDN | Not detected | Cloudflare |
| Frameworks | Not detected | Bootstrap |
| Analytics | Not detected | Google Analytics 4, Google Tag Manager |
| Support stack | Not detected | HubSpot |
What users say
| Measure | Cellply | Element Biosciences |
|---|---|---|
| Reddit sentimentThreads we track | Not published | 1 positive, 0 negative across 3 threads |
“The cost of sequencing human genome has fallen from $100M to under $100 in approximately 25 years. Element Biosciences reportedly hit the $100 genome milestone (Feb 2026).”r/singularity
Cellply vs Element Biosciences: common questions
Which is better, Cellply or Element Biosciences?
On our 0-100 score Element Biosciences rates higher (53/100 against 52/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 13 data points above: read the rows that match what you are buying for.
How do Cellply and Element Biosciences compare on the numbers?
Element Biosciences leads on funding raised ($175M against $7.2M).
What do real users say about Cellply and Element Biosciences?
Element Biosciences: 1 positive and 0 negative mentions across 3 Reddit threads we track, mostly in r/singularity.
Read the full Cellply review and pricing or the Element Biosciences review and pricing. You can also browse other Cellply alternatives we track.